Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 7/20 | 0.49 |
| ▸ | MEN1 | O00255 | 5/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | GFER | P55789 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8655762 | 0.84 | ALDH1A1 (0.41) | MAPTMEN1KMT2ANPSR1ALDH1A1 | |
| SCHEMBL6261662 | 0.83 | ALDH1A1 (0.53) | PTGS2MAPTMEN1KMT2AKDM4E | |
| SCHEMBL10959889 | 0.81 | MAPT (0.38) | PTGS2MAPTMEN1KMT2AKDM4E | |
| SCHEMBL10336884 | 0.80 | PTGS2 (0.40) | PTGS2MAPTMEN1KMT2AKDM4E | |
| SCHEMBL3300508 | 0.80 | PTGS2 (0.43) | PTGS2MAPTMEN1KMT2AKDM4E | |
| SCHEMBL6264097 | 0.79 | ALDH1A1 (0.56) | PTGS2MAPTMEN1KMT2AKDM4E | |
| SCHEMBL8048128 | 0.76 | ALDH1A1 (0.49) | PTGS2MAPTMEN1KMT2AKDM4E | |
| SCHEMBL8048129 | 0.76 | ALDH1A1 (0.38) | PTGS2MAPTMEN1KMT2AKDM4E | |
| SCHEMBL5685523 | 0.76 | MAPT (0.56) | PTGS2MAPTNPSR1CYP1A2CYP2C19 | |
| SCHEMBL594488 | 0.76 | ALDH1A1 (0.47) | MAPTMEN1KMT2AKDM4ENPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1914559-B | Silver halide color photographic light-sensitive material and color image forming method | FUJI PHOTO FILM CO LTD | 2011-09-21 | — | — | CN | disclosed |
| US-7879893-B2 | Zinc binding ligand; sustained release of insulin | NOVO NORDISK A/S (DK) | 2011-02-01 | — | — | US | disclosed |
| US-7732124-B2 | Silver halide color photographic light-sensitive material and color image-forming method | FUJIFILM CORPORATION (JP) | 2010-06-08 | — | — | US | disclosed |
| US-7611829-B2 | Silver halide color photographic light-sensitive material and color image-forming method | FUJIFILM CORPORATION (JP) | 2009-11-03 | — | — | US | disclosed |
| US-20090130613-A1 | Silver Halide color photographic light-sensitive material and color image-forming method | DEGUCHI YASUAKI | 2009-05-21 | — | — | US | disclosed |
| US-20090123563-A1 | Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand | NOVO NORDISK A/S (DK) | 2009-05-14 | — | — | US | disclosed |
| EP-1914594-A2 | Silver halide color photographic light-sensitive material and color image-forming method | FUJIFILM Corporation (JP) | 2008-04-23 | — | — | EP | disclosed |
| EP-1585541-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING INSULIN AND LEGENDS OF INSULIN HEXAMER | NOVO NORDISK AS (DK) | 2007-11-14 | — | — | EP | disclosed |
| US-20070154853-A1 | Silver halide color photographic light-sensitive material and color image-forming method | FUJI PHOTO FILM CO., LTD. (JP) | 2007-07-05 | — | — | US | disclosed |
| EP-1709483-A4 | SILVER HALIDE COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL AND COLOR IMAGE-FORMING METHOD | FUJIFILM CORP (JP) | 2007-06-27 | — | — | EP | disclosed |
| EP-0442323-A2 | Silver halide color reversal photographic material capable of providing interimage effect | FUJI PHOTO FILM CO., LTD. (JP) | 1991-08-21 | — | — | EP | disclosed |
| EP-0436027-A1 | METHOD OF TREATING SILVER HALIDE PHOTOGRAPHIC MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 1991-07-10 | — | — | EP | disclosed |
| US-5006444-A | Silver halide photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1991-04-09 | — | — | US | disclosed |
| EP-0420005-A1 | high contrast silver halide photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1991-04-03 | — | — | EP | disclosed |
| EP-0398285-A2 | Silver halide photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1990-11-22 | — | — | EP | disclosed |
| EP-0395069-A2 | Silver halide photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1990-10-31 | — | — | EP | disclosed |
| EP-0393720-A2 | Silver halide photographic materials | FUJI PHOTO FILM CO., LTD. (JP) | 1990-10-24 | — | — | EP | disclosed |
| EP-0335319-A2 | Silver halide photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1989-10-04 | — | — | EP | disclosed |
| US-4737442-A | INCLUDING A SENSITIZER AND A BLOCKED DEVELOPMENT RESTRAINER; FREE OF BLACK SPOTS | FUJI PHOTO FILM CO., LTD. (JP) | 1988-04-12 | — | — | US | disclosed |
| US-4110338-A | Product and preparation of 1H-tetrazole-5-thiol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1978-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090123563-A1 | Pharmaceutical Preparations Comprising Insulin, Zinc Ions and Zinc-Binding Ligand | IAPP, IRS1, HBB | PTGS2 4802/4885MAPT 1785/4885MEN1 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.